Related Experiment Video
Updated: Jun 15, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Kidney Failure Risk Equation and Risk of Kidney and Cardiovascular Outcomes in Patients with Heart Failure with
Iris E Beldhuis1,2, Brian L Claggett1, Brendon L Neuen1,3
1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Insights
The Kidney Failure Risk Equation (KFRE) predicts cardiovascular events in heart failure (HF) patients with chronic kidney disease (CKD). While not predicting kidney failure directly in this cohort, KFRE scores indicate higher risks for mortality and HF hospitalizations.
Area of Science:
- Nephrology
- Cardiology
- Clinical Prediction Models
Background:
- The Kidney Failure Risk Equation (KFRE) is recommended for predicting kidney failure in chronic kidney disease (CKD).
- Its utility in patients with co-existing heart failure (HF) is not well-established.
- This study investigates KFRE performance in patients with heart failure with reduced ejection fraction (HFrEF) and CKD.
Purpose of the Study:
- To evaluate the association of 2- and 5-year KFRE scores with cardiovascular and kidney outcomes in patients with HFrEF and CKD.
- To explore KFRE performance using continuous scores, risk categories, and quartiles.
Main Methods:
- Analysis of 794 patients with HFrEF and eGFR < 60 ml/min/1.73m² from the PARADIGM-HF trial.
- KFRE score calculation using baseline urine albumin-creatinine ratio (UACR), age, sex, and estimated glomerular filtration rate (eGFR).
- Assessment of associations between KFRE scores and composite kidney outcomes (ESKD or 50% eGFR decline), cardiovascular death, HF hospitalization, and all-cause mortality.
Main Results:
- The median 5-year KFRE score was 0.63%. Higher baseline KFRE scores correlated with higher systolic blood pressure, NT-proBNP, and increased prevalence of diabetes, atrial fibrillation, and diuretic use.
- The 5-year KFRE score was not significantly associated with the composite outcome of ESKD or 50% eGFR decline (HR 1.45, P=0.10).
- Continuous 5-year KFRE scores were significantly associated with cardiovascular death or HF hospitalization (HR 1.22, P<0.001) and all-cause mortality (HR 1.24, P<0.001).
Conclusions:
- The KFRE demonstrates association with cardiovascular event risk in patients with HFrEF and CKD.
- The median KFRE score was low in this cohort, suggesting potential underestimation of risk.
- Validation in HF populations with more advanced CKD is necessary to confirm these findings.
Background And Aims:
The use of the Kidney Failure Risk Equation (KFRE) is guideline recommended in patients with chronic kidney disease (CKD) to predict risk of kidney failure, however, this has not been well studied in patients with heart failure (HF).
Methods:
The KFRE score incorporates baseline urine albumin-creatinine ratio (UACR), age, sex, and estimated glomerular filtration rate (eGFR). Among patients with HF and reduced EF (HFrEF) and CKD in PARADIGM-HF, we explored the association of the 2- and 5-year KFRE score continuously, risk-based categories, and in quartiles with subsequent cardiovascular and kidney outcomes.
Results:
Among 794 patients with HFrEF and eGFR<60 ml/min/1.73m2 with all KFRE variables available, median 5-year KFRE score was 0.63% [0.28%-1.67%]. Patients with higher KFRE baseline score had higher systolic blood pressure and NT-proBNP levels and were more likely to have a history of diabetes or atrial fibrillation, or to be treated with diuretics at baseline. The KFRE 5-year score was not significantly associated with the composite of ESKD or 50% decline in eGFR (HR 1.45; 95% CI 0.93-2.25; P=0.10), although confidence limits were wide in light of few events. Continuous KFRE 5-year score was associated with cardiovascular death or HF hospitalization (HR 1.22; 95% 1.09-1.36; P<0.001) and all-cause mortality (HR 1.24; 95% CI 1.10-1.39; P<0.001).
Conclusions:
These data suggest that the KFRE is associated with risk of cardiovascular events in patients with HFrEF. However, as the median KFRE was low in PARADIGM-HF, these data require validation in HF populations with more advanced CKD.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: Diuretics
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management

